NO177055C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner

Info

Publication number
NO177055C
NO177055C NO910729A NO910729A NO177055C NO 177055 C NO177055 C NO 177055C NO 910729 A NO910729 A NO 910729A NO 910729 A NO910729 A NO 910729A NO 177055 C NO177055 C NO 177055C
Authority
NO
Norway
Prior art keywords
oxetanones
preparation
therapeutically active
analogous process
novel
Prior art date
Application number
NO910729A
Other languages
English (en)
Norwegian (no)
Other versions
NO910729L (no
NO177055B (no
NO910729D0 (no
Inventor
Romano Derungs
Hans Peter Marki
Henri Stalder
Andre Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO910729D0 publication Critical patent/NO910729D0/no
Publication of NO910729L publication Critical patent/NO910729L/no
Publication of NO177055B publication Critical patent/NO177055B/no
Publication of NO177055C publication Critical patent/NO177055C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12Beta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
NO910729A 1990-02-26 1991-02-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner NO177055C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH60490 1990-02-26
CH400590 1990-12-17

Publications (4)

Publication Number Publication Date
NO910729D0 NO910729D0 (no) 1991-02-25
NO910729L NO910729L (no) 1991-08-27
NO177055B NO177055B (no) 1995-04-03
NO177055C true NO177055C (no) 1995-07-12

Family

ID=25685091

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910729A NO177055C (no) 1990-02-26 1991-02-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner

Country Status (18)

Country Link
EP (1) EP0444482B1 (ja)
JP (1) JP2753403B2 (ja)
KR (1) KR0183036B1 (ja)
AT (1) ATE133167T1 (ja)
AU (1) AU645291B2 (ja)
CA (1) CA2035967C (ja)
DE (1) DE59107262D1 (ja)
DK (1) DK0444482T3 (ja)
ES (1) ES2082869T3 (ja)
FI (1) FI115054B (ja)
GR (1) GR3019618T3 (ja)
HU (1) HU218272B (ja)
IE (1) IE72196B1 (ja)
IL (1) IL97148A (ja)
MC (1) MC2226A1 (ja)
NO (1) NO177055C (ja)
NZ (1) NZ237170A (ja)
PT (1) PT96887B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
NL1004559C2 (nl) * 1996-11-18 1998-05-19 Unilife Boter.
CA2358921A1 (en) * 1999-10-29 2001-05-10 John Jason Gentry Mullins Oxetanone derivatives
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
DE102004009076A1 (de) * 2004-02-23 2005-10-27 Solvay Pharmaceuticals Gmbh Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP2212305A4 (en) * 2007-10-31 2011-10-26 Burnham Inst Medical Research BETA-LACTONE COMPOUNDS
BR112020000635B1 (pt) * 2017-07-12 2023-04-18 Mayo Foundation For Medical Education And Research Inibidores de lipases, seus usos e composição farmacêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
JPH0669130B2 (ja) * 1984-08-09 1994-08-31 三菱電機株式会社 遅延線

Also Published As

Publication number Publication date
EP0444482A3 (en) 1991-12-04
PT96887B (pt) 1998-09-30
JP2753403B2 (ja) 1998-05-20
NO910729L (no) 1991-08-27
CA2035967C (en) 2001-10-16
IE910631A1 (en) 1991-08-28
NZ237170A (en) 1993-12-23
HU218272B (en) 2000-07-28
CA2035967A1 (en) 1991-08-27
EP0444482A2 (de) 1991-09-04
ATE133167T1 (de) 1996-02-15
EP0444482B1 (de) 1996-01-17
PT96887A (pt) 1991-10-31
FI910925A (fi) 1991-08-27
NO177055B (no) 1995-04-03
AU7122891A (en) 1991-08-29
ES2082869T3 (es) 1996-04-01
KR0183036B1 (ko) 1999-05-01
FI910925A0 (fi) 1991-02-26
KR910021391A (ko) 1991-12-20
IL97148A (en) 1996-11-14
MC2226A1 (fr) 1993-02-02
NO910729D0 (no) 1991-02-25
AU645291B2 (en) 1994-01-13
GR3019618T3 (en) 1996-07-31
JPH0770099A (ja) 1995-03-14
HUT56557A (en) 1991-09-30
IE72196B1 (en) 1997-03-26
IL97148A0 (en) 1992-05-25
FI115054B (fi) 2005-02-28
DE59107262D1 (de) 1996-02-29
DK0444482T3 (da) 1996-05-06

Similar Documents

Publication Publication Date Title
NO180718C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater
HUT53369A (en) Process for producing substituted pyrrole and pharmaceutical compositions containing them
MA23353A1 (fr) Composes carbamates tricycliques utiles pour l'hinibition de la fonction proteine g
NO177055C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner
DE3885928D1 (de) Verfahren zur Herstellung von parenteral verabreichbaren Chinoloncarbonsäuren.
DK0393424T3 (da) Fremgangsmåde til fremstilling af 2,7-diazabicyclo(3.3.0)octaner
HUT45058A (en) Process for producing 6-hydroxy-methyl-carbapenem derivatives and pharmaceuticals comprising the same as active ingredient
CA2188176A1 (fr) (oxo-1 alkyl) amino-2, deoxy-2 glucopyranoside de dihydroxy - 2,3 propyl, leur procede de preparation et leurs utilisations
DK0751117T3 (da) Fremstilling af bicyclohexanderivat
FR2715656B1 (fr) Procédé de préparation d'anhydride citraconique.
NO911237D0 (no) Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og -kinolizidiner.
DK0614908T3 (da) Fremgangsmåde til fremstilling af 3beta-aminocholansyrederivater.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
DK0551653T3 (da) Enantiomeric pure cis-2-oxa-5,8-diazabicyclo(4.3.0)nonanes and process for their preparation
DE69403615D1 (de) Verfahren zur Herstellung von Epibatidin
ATE110720T1 (de) Verfahren zur herstellung von 2-mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren ester.
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
HUT57746A (en) Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same
SE9003292D0 (sv) Shaft furnace process for ironmaking